Stock listing

NASDAQ:KITE Kite Pharma Inc Stock

Follow Kite Pharma Inc into a list and get an email when it puts out news.

Last close · NASDAQ:KITE

$179.79 USD

Close on Oct 3, 2017 · No longer trades

Jun 20, 2014 to last close +520.0% · weekly closes, Jun 20, 2014 – Oct 3, 2017
Lowest – highest close
$21.39 – $179.81 USDSince Jun 20, 2014 · lowest Jul 16, 2014 · highest Sep 29, 2017

Delisted NASDAQ:KITE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:KITE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Cynthia M. Butitta
Other companies: Autolus Therapeutics plc (Chair of the Compensation Committee, Member of the Audit Committee · Since at least Mar 18, 2026); Century Therapeutics, Inc. (Director · Since at least Jun 17, 2021); Olema Pharmaceuticals, Inc. (Director · Since at least Aug 12, 2020); UroGen Pharma Ltd. (of the Audit Committee · Since at least Jan 1, 2019)
Chief Operating Officer · Jun 19, 2014 – Oct 3, 2017 · Past
Timothy L Moore
Other companies: BioLife Solutions, Inc. (Director · Since at least Sep 1, 2022); Cerus Corporation (Director · Since at least Sep 5, 2018); Allogene Therapeutics, Inc. (Chief Technical Officer · Apr 24, 2023 – Feb 3, 2025 · Past); Instil Bio, Inc. (Chief Operating Officer · Sep 6, 2022 – Sep 6, 2022 · Past)
EVP, Technical Operations · Mar 15, 2016 – Oct 3, 2017 · Past
Jonathan M Peacock
Other companies: Avantor, Inc. (Director · May 16, 2019 – May 8, 2025 · Past); Bellerophon Therapeutics Inc (Director · Feb 13, 2015 – Mar 31, 2021 · Past); Amgen Inc. (EVP & CFO · Apr 25, 2013 – Oct 28, 2013 · Past)
Director · Jun 19, 2014 – Oct 3, 2017 · Past
Jeffrey WiezorekSVP Clinical Development · Jul 15, 2015 – Oct 3, 2017 · Past
Paul L JenkinsonChief Financial Officer · May 16, 2016 – Oct 3, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Kite Pharma Inc.